Ana Sánchez

935 total citations
19 papers, 126 citations indexed

About

Ana Sánchez is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Ana Sánchez has authored 19 papers receiving a total of 126 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Ana Sánchez's work include Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (3 papers) and Alcohol Consumption and Health Effects (3 papers). Ana Sánchez is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), Cancer Treatment and Pharmacology (3 papers) and Alcohol Consumption and Health Effects (3 papers). Ana Sánchez collaborates with scholars based in Spain, United States and Italy. Ana Sánchez's co-authors include Luis Paz‐Ares, Javier García del Pozo, María Carmen Riesco Martínez, Rocio García‐Carbonero, Pablo Tolosa, Eva Ciruelos Gil, Valentina Boni, José López, Raquel Molina and Ana López‐Alfonso and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Urology.

In The Last Decade

Ana Sánchez

18 papers receiving 123 citations

Peers

Ana Sánchez
Sara Bosio Italy
Alexandra M. Adams United States
Carlos Anselmo Lima Brazil
Yohei Hamanaka Japan
Lucía Viola Colombia
Chengping Hu China
Myria Galazi United Kingdom
Wan Qin Chong Singapore
Amy Woodruff United States
Federica Urbano Italy
Sara Bosio Italy
Ana Sánchez
Citations per year, relative to Ana Sánchez Ana Sánchez (= 1×) peers Sara Bosio

Countries citing papers authored by Ana Sánchez

Since Specialization
Citations

This map shows the geographic impact of Ana Sánchez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Sánchez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Sánchez more than expected).

Fields of papers citing papers by Ana Sánchez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Sánchez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Sánchez. The network helps show where Ana Sánchez may publish in the future.

Co-authorship network of co-authors of Ana Sánchez

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Sánchez. A scholar is included among the top collaborators of Ana Sánchez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Sánchez. Ana Sánchez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Montes, A., et al.. (2024). Encapsulation of Olive (Olea europaea L.) Pruning Waste Particles by Supercritical CO2 Technology. Foods. 13(6). 905–905. 2 indexed citations
2.
Sánchez-Bayona, Rodrigo, Ana Sánchez, Isabel Echavarría, et al.. (2024). Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohort. Breast Cancer Research and Treatment. 206(3). 551–559. 7 indexed citations
3.
Sánchez, Ana, et al.. (2023). Dalbavancin for Successful Treatment of Infective Endocarditis Caused by Enterococcus faecalis. European Journal of Case Reports in Internal Medicine. 10(1). 2 indexed citations
4.
Sánchez-Bayona, Rodrigo, Ana Sánchez, Luís Manso, et al.. (2022). Abstract P5-13-24: Efficacy of first line CDK4/6 inhibitors in HER2-low vs HER2-zero, hormone receptor positive, HER2 negative metastatic breast cancer. Cancer Research. 82(4_Supplement). P5–13. 2 indexed citations
5.
Cortellini, Alessio, Elisa Roldán, Margarita García, et al.. (2021). 1560O Prevalence and impact of COVID-19 sequelae on treatment pathways and survival of cancer patients who recovered from SARS-CoV-2 infection. Annals of Oncology. 32. S1130–S1130. 3 indexed citations
6.
7.
Sánchez-Bayona, Rodrigo, A.M. Castro Luna, Pablo Tolosa, et al.. (2021). 22P HER2-low vs HER2-zero metastatic breast carcinoma: A clinical and genomic descriptive analysis. Annals of Oncology. 32. S29–S30. 10 indexed citations
8.
9.
Ibernón, Meritxell, et al.. (2020). The impact of COVID‐19 in hemodialysis patients: Experience in a hospital dialysis unit. Hemodialysis International. 25(2). 205–213. 8 indexed citations
10.
Cejalvo, Juan Miguel, Lucía Carril-Ajuria, Begoña Bermejo, et al.. (2020). 57P Benefit of CDK4/6 inhibitors beyond PIK3CA mutations in metastatic breast cancer patients. Annals of Oncology. 31. S35–S35. 2 indexed citations
11.
Tolosa, Pablo, et al.. (2020). Biology of the Triple-Negative Breast Cancer: Immunohistochemical, RNA, and DNA Features. Breast Care. 15(3). 208–216. 7 indexed citations
12.
Tolosa, Pablo, Ana Sánchez, Rodrigo Sánchez-Bayona, et al.. (2020). Abstract PO-020: Impact of CDK 4/6i withdrawal or dose adjustment on COVID-19 incidence in HR+/HER2- mBC patients during the pandemic. Clinical Cancer Research. 26(18_Supplement). PO–20. 1 indexed citations
13.
Sánchez, Ana, et al.. (2018). Necitumumab for the Treatment of Advanced Non-Small-Cell Lung Cancer. Future Oncology. 15(7). 705–716. 31 indexed citations
14.
Martínez, María Carmen Riesco, Ana Sánchez, & Rocio García‐Carbonero. (2017). Safety and efficacy of nintedanib for the treatment of metastatic colorectal cancer. Expert Opinion on Investigational Drugs. 26(11). 1295–1305. 8 indexed citations
15.
Sánchez, Ana, et al.. (2014). Análisis de las caídas en personas institucionalizadas. Metas de Enfermería. 17(6). 50–55.
16.
Sánchez, Ana, et al.. (2013). [Hospital emergency events related with alcohol consumption in young. Castile and Leon, Spain].. PubMed. 86(4). 409–17. 1 indexed citations
17.
18.
Sánchez, Ana, et al.. (2010). Evolución del consumo de drogas por inmigrantes entre los años 2004 y 2008. Gaceta Sanitaria. 24(3). 200–203. 6 indexed citations
19.
Sánchez, Ana, et al.. (2000). DOXAZOSIN AND PRIAPISM. The Journal of Urology. 163(1). 238–238. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Bosio Breakdown of academic impact, for papers by Alexandra M. Adams Breakdown of academic impact, for papers by Carlos Anselmo Lima Breakdown of academic impact, for papers by Yohei Hamanaka Breakdown of academic impact, for papers by Lucía Viola Breakdown of academic impact, for papers by Chengping Hu Breakdown of academic impact, for papers by Myria Galazi Breakdown of academic impact, for papers by Wan Qin Chong Breakdown of academic impact, for papers by Amy Woodruff Breakdown of academic impact, for papers by Federica Urbano
Rankless by CCL
2026